Search for Potential Non-Steroidal Inhibitors of 17 &bgr;-Hydroxysteroid Dehydrogenase (17 &bgr;-HSD) in the Treatment of Hormone-Dependent Cancers

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|4|3|180-184

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.4, Iss.3, 2007-04, pp. : 180-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrone (E1) Based Esters as Potential Inhibitors of Type 3 17&bgr;- hydroxysteroid Dehydrogenase (17&bgr;-HSD3) in the Treatment of Hormone-Dependent Prostate Cancer

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 9, 2010-11 ,pp. : 650-656

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and In Vitro Evaluation of 4-Androstene-3,17-dione/Adenosine Hybrid Compounds as Bisubstrate Inhibitors of Type 3 17&bgr;-Hydroxysteroid Dehydrogenase

By  

Medicinal Chemistry, Vol. 2, Iss. 4, 2006-01 ,pp. : 329-347

Bentham Science Publishers

Access to resources Recommend Favorite

Type 1 11 &bgr;-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 3, 2006-09 ,pp. : 259-269

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers

By Smith H.J.   Nicholls P.J.   Simons C.   Lain R.L.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 789-824

Informa Healthcare

Access to resources Recommend Favorite

Selective Modulation of A&bgr;42 Production in Alzheimer's Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4337-4355

Bentham Science Publishers

Access to resources Recommend Favorite